Sign In
Buy HAE
$65.88
-0.490 (-0.738%)
At Close: Jun 03, 2026
Haemonetics (HAE) Q4 2020 Earnings Call Transcript
01:01am, Wednesday, 06'th May 2020
HAE earnings call for the period ending March 31, 2020.
Edited Transcript of HAE earnings conference call or presentation 5-May-20 12:00pm GMT
09:24pm, Tuesday, 05'th May 2020
Q4 2020 Haemonetics Corp Earnings Call
Needham Maintains Buy on Haemonetics, Lowers Price Target to $132
05:16pm, Tuesday, 05'th May 2020Haemonetics Q4 EPS $0.690 Misses $0.730 Estimate, Sales $238.492M Miss $247.150M Estimate
10:12am, Tuesday, 05'th May 2020
Here's a roundup of top developments in the biotech space over the last 24 hours:
Scaling The Peaks
(Biotech stocks hitting 52-week highs May 5.)
Arcturus Therapeutics Ltd (...
Royce Investment Partners: Premier Quality- An Update and Outlook
08:41pm, Monday, 04'th May 2020
By Chuck Royce, Lauren Romeo and Steven McBoyle Continue reading...
Eaton Vance Worldwide Health Sciences Fund Adds 3 Stocks to Portfolio
05:36pm, Monday, 04'th May 2020
Fund reveals 1st-quarter trades Continue reading...
What's in Store for Becton, Dickinson's (BDX) Q2 Earnings?
03:02pm, Monday, 04'th May 2020
Becton, Dickinson's (BDX) fiscal second-quarter results likely to reflect robust performance at BD Life Sciences. However, forex is likely to have remained a woe.
Why Earnings Season Could Be Great for Haemonetics (HAE)
01:08pm, Monday, 04'th May 2020
Haemonetics (HAE) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season.
Eaton Vance Worldwide Health Sciences Fund Adds ' Stocks to Portfolio
12:00am, Monday, 04'th May 2020The Week Ahead In Biotech: Smid-Cap Earnings News Flow Picks Up Pace
12:00am, Sunday, 03'rd May 2020
Biotech stocks started last week on a strong note but the upward momentum slowed through the week. The week saw a slew of earnings from big pharma names, including Merck...
PerkinElmer (PKI) to Report Q1 Earnings: What's in Store?
10:50am, Friday, 01'st May 2020
PerkinElmer's (PKI) first-quarter results likely to reflect top-line growth and robust performance at Diagnostics segment. However, forex is likely to have remained a woe.
Haemonetics Co. (NYSE:HAE) Given Consensus Recommendation of "Buy" by Analysts
06:52am, Friday, 01'st May 2020
Haemonetics Co. (NYSE:HAE) has earned a consensus recommendation of “Buy” from the nine ratings firms that are covering the firm, Marketbeat Ratings reports. One analyst has rated the stock with a
Russell 2000 Retreats
04:12pm, Thursday, 30'th Apr 2020
The Russell 2000 Index is pulling back today after hitting a major resistance level yesterday.
